- FDA approves Orca Bio’s cell therapy to improve transplant outcomesThe FDA gave the go-ahead to Orca Bio’s T cell therapy that would reduce transplant-related complications for blood cancer patients. The therapy will be branded as Tregzi, an homage to the regulato…Endpoints · 27d ago↗ source
- BridgeBio gets funding for drug launch; United buys into cell therapyElsewhere, Otsuka’s kidney drug hit the goal of a confirmatory trial and Vertex’s CRISPR sickle cell drug secured expanded approval.BioPharma Dive · 27d ago↗ source
- STAT+: The moment Anthropic convinced me it’s serious about scienceAI Prognosis: The release of Claude Science suggests big model makers are getting serious about real science, and not just flashy problems.STAT · 27d ago